4//SEC Filing
Walker Luke Nathaniel 4
Accession 0000950170-24-003369
CIK 0001708493other
Filed
Jan 8, 7:00 PM ET
Accepted
Jan 9, 4:30 PM ET
Size
5.4 KB
Accession
0000950170-24-003369
Insider Transaction Report
Form 4
Walker Luke Nathaniel
Chief Medical Officer
Transactions
- Award
Common Stock
2024-01-07+115,000→ 135,000 total
Footnotes (2)
- [F1]The grant of restricted stock units ("RSUs") to the Reporting Person as reported herein was approved by the Issuer's Compensation Committee on January 7, 2024 ("Grant Date") as part of the Issuer's annual grant of equity awards in the ordinary course. Each RSU represents a contingent right to receive one share of the Issuer's common stock, issuable upon the vesting and settlement of RSUs.
- [F2]The RSUs vest quarterly over four years from the Grant Date, subject to acceleration and vesting in full upon a Change in Control (as defined in the Issuer's 2019 Equity Incentive Plan) of the Issuer, and subject to the continuing service of the Reporting Person on each vesting date.
Documents
Issuer
Harpoon Therapeutics, Inc.
CIK 0001708493
Entity typeother
Related Parties
1- filerCIK 0001701440
Filing Metadata
- Form type
- 4
- Filed
- Jan 8, 7:00 PM ET
- Accepted
- Jan 9, 4:30 PM ET
- Size
- 5.4 KB